VNDA earnings
Vanda Pharmaceuticals (VNDA) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- VNDA reports next on Feb 10, 2027, with EPS of -0.32 expected.
- VNDA beat EPS estimates in 9 of its last 16 reports.
VNDA earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 28, 2026 | -0.37 | -0.68 | 45.75% | $69.81M |
| Q2 2026 | Aug 5, 2026 | -1.04 | -0.58 | -78.54% | $50.53M |
| Q1 2026 | May 6, 2026 | -0.82 | -0.53 | -54.72% | $51.72M |
| Q4 2025 | Feb 11, 2026 | -2.39 | -2.18 | -9.63% | $57.22M |
| Q3 2025 | Oct 29, 2025 | -0.38 | -0.31 | -22.58% | $56.26M |
| Q2 2025 | Jul 31, 2025 | -0.46 | -0.34 | -35.29% | $52.59M |
| Q1 2025 | May 7, 2025 | -0.50 | -0.55 | 9.09% | $50.04M |
| Q4 2024 | Feb 13, 2025 | -0.08 | -0.14 | 42.86% | $53.19M |
| Q3 2024 | Nov 6, 2024 | -0.09 | -0.17 | 47.06% | $47.65M |
| Q2 2024 | Jul 31, 2024 | -0.08 | -0.21 | 61.90% | $50.47M |
| Q1 2024 | May 8, 2024 | -0.07 | 0.05 | -240.00% | $47.46M |
| Q4 2023 | Feb 7, 2024 | -0.04 | -0.09 | 55.56% | $45.27M |
| Q3 2023 | Nov 8, 2023 | 0.00 | 0.00 | 100.00% | $38.81M |
| Q2 2023 | Jul 27, 2023 | 0.03 | -0.13 | 123.08% | $46.06M |
| Q1 2023 | May 3, 2023 | 0.06 | – | – | $62.50M |
| Q4 2022 | Feb 8, 2023 | 0.12 | 0.08 | 50.00% | $64.48M |
| Q3 2022 | Nov 2, 2022 | 0.06 | 0.09 | -33.33% | $65.32M |